|
|
- 2017
胰高血糖素样肽-1改善过氧化氢诱导的血管内皮氧化损伤
|
Abstract:
摘要 目的探讨胰高血糖素样肽-1(GLP-1)对过氧化氢(H2O2)诱导的内皮细胞氧化损伤的保护作用及机制.方法:取人脐静脉内皮细胞(HUVECs),分为正常对照组、H2O2组、GLP-1组、H2O2+浓度10 nmol/L GLP-1组、H2O2+浓度100 nmol/L GLP-1组、 H2O2+浓度1 000 nmol/L GLP-1组.采用荧光显微镜检测细胞内活性氧自由基(ROS)水平、观察细胞骨架F-actin变化;采用流式细胞仪检测细胞凋亡比率;Western Blotting检测磷酸化的雷帕霉素靶蛋白(p-mTOR)蛋白水平;实时荧光定量聚合酶链反应(QPCR)检测抗氧化酶:过氧化氢酶(CAT)、超氧化物歧化酶2(SOD2)和谷胱甘肽过氧化物酶1(GPX1)基因的表达变化.结果:H2O2组细胞骨架破坏明显,细胞内ROS含量增加,细胞凋亡率增加;加入GLP-1后,细胞骨架破坏受到显著抑制,ROS含量减少,凋亡率降低.Western Blotting结果显示,H2O2组p-mTOR表达降低, GLP-1可以提高p-mTOR表达,使蛋白水平趋于正常;加入GLP-1受体拮抗剂艾塞纳肽(9~36)后,GLP-1不能上调p-mTOR表达.H2O2作用后,CAT、SOD2和GPX1基因表达降低,而GLP-1可以逆转这些基因表达的降低.结论:GLP-1通过上调抗氧化应激酶对抗H2O2诱导的内皮细胞损伤,且可能是通过活化mTOR 通路起保护作用.
| [1] | OESEBURG H, de BOER R A, BUIKEMA H, et al. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A[J]. Arteriosclerosis, Thrombosis, and Vascular Biology, 2010, 30(7): 1407-1414. |
| [2] | GIACCO F, BROWNLEE M. Oxidative stress and diabetic complications[J]. Circulation Research, 2010, 107(9): 1058-1070. |
| [3] | WANG R, LU L, GUO Y, et al. Effect of glucagon-like peptide-1 on high-glucose-induced oxidative stress and cell apoptosis in human endothelial cells and its underlying mechanism[J]. J Cardiovasc Pharmacol, 2015, 66(2): 135-140. |
| [4] | HE Q, SHA S, SUN L, et al. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway[J]. Biochem Biophys Res Commun, 2016, 476(4): 196-203. |
| [5] | KIMURA R, OKOUCHI M, FUJIOKA H, et al. Glucagon-like peptide-1 (GLP-1) protects against methylglyoxal-induced PC12 cell apoptosis through the PI3K/Akt/mTOR/GCLc/redox signaling pathway[J]. Neuroscience, 2009, 162(4): 1212-1219. |
| [6] | HONG X, ZHANG H, LIANG H, et al. Exendin-4 decreases ghrelin levels through mTOR signaling[J]. Molecular and Cellular Endocrinology, 2016, 437: 201-212. |
| [7] | ZHOU Y, HE X, CHEN Y, et al. Exendin-4 attenuates cardiac hypertrophy via AMPK/mTOR signaling pathway activation[J]. Biochemical and Biophysical Research Communications, 2015, 468(1/2): 394-399. |
| [8] | SHIRAKI A, OYAMA J, KOMODA H, et al. The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells[J]. Atherosclerosis, 2012, 221(2): 375-382. |
| [9] | WANG W, WANG W H, AZADZOI K M, et al. Alu RNA accumulation in hyperglycemia augments oxidative stress and impairs eNOS and SOD2 expression in endothelial cells[J]. Molecular and Cellular Endocrinology, 2016, 426: 91-100. |
| [10] | HULMI J J, SILVENNOINEN M, LEHTI M, et al. Altered REDD1, myostatin, and Akt/mTOR/FoxO/MAPK signaling in streptozotocin-induced diabetic muscle atrophy[J]. AJP: Endocrinology and Metabolism, 2012, 302(3): E307-E315. |
| [11] | SHEU M L, HO F M, YANG R S, et al. High glucose induces human endothelial cell apoptosis through a phosphoinositide 3-kinase-regulated cyclooxygenase-2 pathway[J]. Arterioscler Thromb Vasc Biol, 2005, 25(3): 539-545. |
| [12] | CAO Y, ZHANG Y, QI J, et al. Ferulic acid inhibits H 2 O 2 -induced oxidative stress and inflammation in rat vascular smooth muscle cells via inhibition of the NADPH oxidase and NF-κB pathway[J]. International Immunopharmacology, 2015, 28(2): 1018-1025. |
| [13] | WANG D, LUO P, WANG Y, et al. Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism[J]. Diabetes, 2013, 62(5): 1697-1708. |
| [14] | van GENUGTEN R E, MOLLER-GOEDE D L, van RAALTE D H, et al. Extra-pancreatic effects of incretin-based therapies: potential benefit for cardiovascular-risk management in type 2 diabetes[J]. Diabetes Obes Metab, 2013, 15(7): 593-606. |
| [15] | LIU Z, STANOJEVIC V, BRINDAMOUR L J, et al. GLP1-derived nonapeptide GLP1(28-36)amide protects pancreatic-cells from glucolipotoxicity[J]. Journal of Endocrinology, 2012, 213(2): 143-154. |
| [16] | DRUCKER D J. The biology of incretin hormones[J]. Cell Metab, 2006, 3(3): 153-165. |
| [17] | ZHAN Y, SUN H L, CHEN H, et al. Glucagon-like peptide-1 (GLP-1) protects vascular endothelial cells against advanced glycation end products (AGEs)-induced apoptosis[J]. Med Sci Monit, 2012, 18(7): R286-R291. |
